303 Similarly, oral administration of pectin, another dietary polysaccharide fiber, can largely improve the efficacy of anti-PD-1 mAbs by increasing the number of butyrate-producing bacteria, which is sufficient to promote T-cell infiltration and activation in the TME
Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained
In April, the board announced that it was extending the search process as well as Battle's time in the position until December
Kalkan, I
primary-cta How to Access GHK-Cu Through Licensed Providers Eden enables access to licensed healthcare providers who evaluate personal wellness goals and determine whether compounded medications, such as GHK-Cu, may be appropriate
Machine learning and deep learning are the key aspects of AI in breast cancer imaging
